Document is current
Any future updates will be listed below
-
Authors
Mansfield, Megan E.
Volpi, Connor R.
John, Chama
Adebiyi, Ruxton
Mitchell, Andrew
Aigoro, Jumoke A.
Bawa, Yerima Jibrin
Kolawole, Kazeem E.
Ononaku, Uchenna
Jibrin, Paul
Olaomi, Oluwole
Agbo, Francis
Aka, Abayomi
Bentzen, Søren M.
Goldstone, Stephen E.
Dakum, Patrick
Palefsky, Joel M.
Knott, Cheryl
Adebajo, Sylvia
Nowak, Rebecca G.
-
Funding
Funding for this research was provided by:
National Cancer Institute (U01CA275053, U01CA275053, U01CA275053, U01CA275053, U01CA275053, U01CA275053, U01CA275053, U01CA275053, U01CA275053, U01CA275053, U01CA275053, U01CA275053, U01CA275053, U01CA275053, U01CA275053, U01CA275053, U01CA275053)
U.S. President’s Emergency Plan for AIDS Relief (NU2GGH002099)
Maryland Department of Health (CH-649-CRF)
- License Information
-
More Information
Article History
Received: 8 October 2024
Accepted: 26 September 2025
First Online: 14 November 2025
Declarations
:
: This study has been reviewed and approved by the Federal Capital Territory Health Research Ethics Committee, National Health Research Ethics Committee of Nigeria, the Clinical Research Committee at the University of Maryland Greenebaum Comprehensive Cancer Center, and the University of Maryland, Baltimore Institutional Review Board. Informed consent was obtained by all participants who enrolled in the study. All methods were performed in accordance with the relevant guidelines and regulations.
: All participants reviewed, discussed, and voluntarily signed the approved consent form prior to data collection.
: The authors declare no competing interests.
